The CD16-CD56bright NK cell subset is resistant to reactive oxygen species produced by activated Granulocytes and has higher antioxidative capacity than the CD16+CD56dim subset

被引:61
作者
Harlin, Helena
Hanson, Mikael
Johansson, C. Christian
Sakurai, Daiju
Poschke, Isabel
Norell, Hakan
Malmberg, Karl-Johan
Kiessling, Rolf
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden
关键词
D O I
10.4049/jimmunol.179.7.4513
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human NK cells can be divided into CD56(dim) and CD56(bright) subsets. These two types of NK cells respond to different types of stimuli, with CD56(dim) NK cells having direct cytotoxic ability and CD56(bright) NK cells having mainly an immunoregulatory function. We show that the CD16(+)CD56(dim) NK subset is characterized by sensitivity to cell death induced by activated granulocytes. We identified hydrogen peroxide (H2O2) as the major effector molecule responsible for the cytotoxic effect of granulocytes on CD56(dim) NK cells, because the ability of granulocytes to kill CD56(dim) NK cells was completely abrogated in the presence of the hydrogen peroxide scavenger catalase. When exposing NK cells to H2O2, CD56(dim) cells showed rapid mitochondrial depolarization and down-regulation of activating NKRs, eventually resulting in cell death, whereas CD56(bright) cells remained unaffected. The difference in sensitivity to H2O2 was mirrored by a difference in intracellular oxidation levels between CD56(dim) and CD56(bright) NK cells, and cell lysates from the latter subset possessed a greater ability to block H2O2-mediated oxidation. Our data may explain the preferential accumulation of CD56(bright) NK cells often seen in environments rich in reactive oxygen species, such as at sites of chronic inflammation and in tumors.
引用
收藏
页码:4513 / 4519
页数:7
相关论文
共 51 条
[1]   LYMPHOKINE-ACTIVATED KILLER (LAK) AND MONOCYTE-MEDIATED CYTO-TOXICITY ON TUMOR-CELL LINES RESISTANT TO ANTITUMOR AGENTS [J].
ALLAVENA, P ;
DAMIA, G ;
COLOMBO, T ;
MAGGIONI, D ;
DINCALCI, M ;
MANTOVANI, A .
CELLULAR IMMUNOLOGY, 1989, 120 (01) :250-258
[2]   Human CD56bright CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobocterium bovis bacillus Calmette-Guerin [J].
Batoni, G ;
Esin, S ;
Favilli, F ;
Pardini, M ;
Bottai, D ;
Maisetta, G ;
Florio, W ;
Campa, M .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 62 (06) :498-506
[3]   Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer [J].
Bauernhofer, T ;
Kuss, I ;
Henderson, B ;
Baum, AS ;
Whiteside, TL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) :119-124
[4]   Evidence for NK cell subsets based on chemokine receptor expression [J].
Berahovich, Robert D. ;
Lai, Nu L. ;
Wei, Zheng ;
Lanier, Lewis L. ;
Schall, Thomas J. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (11) :7833-7840
[5]   Down-regulation of the T cell receptor CD3ζ chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness [J].
Berg, L ;
Rönnelid, J ;
Klareskog, L ;
Bucht, A .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01) :174-182
[6]   Oxygen radical-induced natural killer cell dysfunction:: role of myeloperoxidase and regulation by serotonin [J].
Betten, Å ;
Dahlgren, C ;
Mellqvist, UH ;
Hermodsson, S ;
Hellstrand, K .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (06) :1111-1115
[7]  
Betten Å, 2001, J LEUKOCYTE BIOL, V70, P65
[8]   An NAD(P)H oxidase regulates growth and transcription in melanoma cells [J].
Brar, SS ;
Kennedy, TP ;
Sturrock, AB ;
Huecksteadt, TP ;
Quinn, MT ;
Whorton, AR ;
Hoidal, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 282 (06) :C1212-C1224
[9]   NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily [J].
Cantoni, C ;
Bottino, C ;
Vitale, M ;
Pessino, A ;
Augugliaro, R ;
Malaspina, A ;
Parolini, S ;
Moretta, L ;
Moretta, A ;
Biassoni, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :787-795
[10]  
Cooper GJS, 2001, AUST J DAIRY TECHNOL, V56, P97